Paul A. Andrews

Short-termcis-diamminedichloroplatinum(II) accumulation in sensitive and resistant human ovarian carcinoma cells

Stephen C. Mann, Paul A. Andrews, Stephen B. Howell · Cancer Chemotherapy and Pharmacology · 1990 · 352 citations

Medicine, Oncology, Pharmacology +12

Reductive activation of mitomycin C and mitomycin C metabolites catalyzed by NADPH-cytochrome P-450 reductase and xanthine oxidase.

Shengze Pan, Paul A. Andrews, Constance J. Glover et al. · Journal of Biological Chemistry · 1984 · 214 citations · Full text

Life Sciences, Biochemistry, Cellular Metabolism +14

Differential potentiation of alkylating and platinating agent cytotoxicity in human ovarian carcinoma cells by glutathione depletion.

Paul A. Andrews, Michael P. Murphy, Stephen B. Howell · PubMed · 1985 · 194 citations

Medicine, Oncology, Pharmacology +16

High-dose cisplatin with sodium thiosulfate protection.

C E Pfeifle, Stephen B. Howell, R D Felthouse et al. · Journal of Clinical Oncology · 1985 · 152 citations

Pharmacy, Pharmacokinetics, Pharmacology +17

Rapid Emergence of Acquired <i>cis</i>-Diamminedichloroplatinum(II) Resistance in an In Vivo Model of Human Ovarian Carcinoma

Paul A. Andrews, Jeffrey A. Jones, Nissi Varki et al. · Cancer Communications · 1990 · 131 citations

Medicine, Oncology, Pharmacology +17